Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

Código QR

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammad Shehab, Fatema Alrashed, Robert Battat, Israa Abdullah
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/fbd7085924c8484b8098aba04479277d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Efficacy of bowel preparation regimens for colon capsule endoscopy: a systematic review and meta-analysis
por: Thomas Bjoersum-Meyer, et al.
Publicado: (2021)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
por: Christine Beran, et al.
Publicado: (2021)

Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease
por: S. Sahin, et al.
Publicado: (2021)

The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia
por: Kee‐Huat Chuah, et al.
Publicado: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
por: Kaleb Bogale, et al.
Publicado: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
por: Peter M Irving, et al.
Publicado: (2021)

Systematic Therapy for Gastrointestinal Tumors
por: Zhongguang Luo, et al.
Publicado: (2021)

Is it time we split bowel preparation for all colonoscopies? Outcomes from a national survey of bowel preparation practice in the UK
por: Thomas Archer, et al.
Publicado: (2021)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
por: Henit Yanai, et al.
Publicado: (2021)

Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies
por: Paul Middleton, et al.
Publicado: (2021)

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Shahla Rezaei, et al.
Publicado: (2021)

Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial
por: Zhen-wen Wu, et al.
Publicado: (2021)

Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis
por: Daniel Segna, et al.
Publicado: (2021)

Automated detection of cecal intubation with variable bowel preparation using a deep convolutional neural network
por: Daniel J. Low, et al.
Publicado: (2021)

Transpancreatic precut papillotomy versus double-guidewire technique in difficult biliary cannulation: a systematic review and meta-analysis
por: Edson Guzmán-Calderón, et al.
Publicado: (2021)

Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis
por: Enrique Rodríguez de Santiago, et al.
Publicado: (2021)

Bowel cleansing efficacy for colonoscopy: prospective, randomized comparative study of same-day dosing with 1-L and 2-L PEG + ascorbate
por: Cátia Arieira, et al.
Publicado: (2021)

Deep learning and capsule endoscopy: automatic identification and differentiation of small bowel lesions with distinct haemorrhagic potential using a convolutional neural network
por: Guilherme Macedo, et al.
Publicado: (2021)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)

Systemic vascular resistance in cirrhosis: a predictor of severity?
por: Gaduputi V, et al.
Publicado: (2014)

CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center
por: Hossein Karim, et al.
Publicado: (2020)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt SJ, et al.
Publicado: (2014)

Severe acute ischemic colitis: What is the place of endoscopy in the management strategy?
por: Diane Lorenzo, et al.
Publicado: (2021)

Review of exclusive enteral therapy in adult Crohn’s disease
por: Nikola Mitrev, et al.
Publicado: (2021)

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
por: Ismail MH, et al.
Publicado: (2011)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021)

An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
por: ZHANG Yue
Publicado: (2021)

Antiviral therapy for chronic hepatitis B in the indeterminate phase is urgent
por: JIANG Jun
Publicado: (2021)

Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review
por: Ghassan El Sayed, et al.
Publicado: (2021)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes JA, et al.
Publicado: (2015)

Do gastroenterologists have medical inertia towards coeliac disease? A UK multicentre secondary care study
por: Hugo A Penny, et al.
Publicado: (2021)

Digital Rectal Examination Is a Valuable Bedside Tool for Detecting Dyssynergic Defecation: A Diagnostic Study and a Meta-Analysis
por: Jie Liu, et al.
Publicado: (2021)

How far are we from the “Treat all” era of antiviral therapy for chronic hepatitis B
por: DING Yang
Publicado: (2021)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
por: Kamal SM
Publicado: (2014)

Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis
por: YU Weiming
Publicado: (2021)

Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy
por: XU Jinghang
Publicado: (2021)

Patients in the indeterminate phase of chronic hepatitis B virus infection should receive active antiviral therapy
por: WANG Jingyue
Publicado: (2021)

Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
por: Janardhan SV, et al.
Publicado: (2015)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim TR
Publicado: (2014)

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
por: Korenaga K, et al.
Publicado: (2011)